Donald Notman | Chief Financial Officer |
Antony Mattessich | President & Chief Executive Officer |
Rabia Ozden | Chief Medical Officer |
Steve Meyers | Senior Vice President of Commercial |
Jon Wolleben | JMP Securities |
Joe Catanzaro | Piper Sandler |
Tara Bancroft | Cowen |
Colleen Kusy | Baird |
Yi Chen | H.C. Wainwright |
Caroline Palomeque | Berenberg Capital Markets |
Good day, and thank you for standing by. Welcome to the Ocular Therapeutics First Quarter 2023 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Donald Notman, Chief Financial Officer.